Navigation Links
InterMune to Release First Quarter Financial Results on April 30
Date:4/21/2009

BRISBANE, Calif., April 21 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) announced today that it will release first quarter 2009 financial results on Thursday, April 30, 2009 at 4:00 p.m. Eastern time. A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day.

To access the live teleconference, dial 888-799-0528 (U.S.) or 973-200-3372 (international), conference ID# 95970767. To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

A replay of the webcast and teleconference will be available approximately three hours after the call. The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 95970767.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes pirfenidone for which a Phase 3 program in patients with IPF (CAPACITY) has been completed and the compound is currently in the pre-registration stage. The company also has a research program focused on a pirfenidone analog named ITMN-520. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) expected to enter Phase 2b in the summer of 2009 and a second-generation HCV protease inhibitor research program. For additional informa
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... In response to its clients’ ... sales, training and consumer engagement challenges, digital ... applications to turn their clients’ visions into reality. ... mobile app creations, are now featured on its ... with Toyota, StudioPMG created a robust cross-platform mobile ...
(Date:10/1/2014)... California (PRWEB) October 01, 2014 ... the National Science Foundation to expand their bioCAD/CAM software ... build and modify DNA. The Small Business Innovation Research ... the “j5” technology under exclusive license from the Lawrence ... Joint BioEnergy Institute , an LBNL laboratory that develops ...
(Date:9/30/2014)... German . , ... in a semiconductor layer. Quantum dots are small structures that ... a short laser pulse is fired at the photonic crystal, ... a change in the electromagnetic field around it. This change ... by the dot. As soon as the refractive index recovers ...
(Date:9/30/2014)... 30, 2014 Pacific Northwest Biotechnology, LLC ... Global Markets Direct,s, ,Pacific Northwest Biotechnology, LLC ... overview of the Pacific Northwest Biotechnology, LLC,s pharmaceutical ... comprehensive information on the current therapeutic developmental pipeline ... analysis at various stages, therapeutics assessment by drug ...
Breaking Biology Technology:Digital Agency Studio PMG Launches New Case Studies on Website 2TeselaGen Receives $750k NSF SBIR Phase II Award 2TeselaGen Receives $750k NSF SBIR Phase II Award 3Ultrafast remote switching of light emission 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3
... gather a burgeoning number of stem cell researchers into ... of Wisconsin-Madison has established the new Wisconsin Stem Cell ... UW-Madison Graduate School, the new initiative is intended to ... develop new resources and opportunities for as many as ...
... announced today that The Valley Hospital , ... in Ridgewood, N.J., has successfully implemented API's Payrollmation time ... ,Payrollmation automates time and attendance data collection and ... will improve employee morale and help the organization to ...
... University of Wisconsin-Madison students will compete for $22,000 ... G. Steve Burrill Technology Business Plan Competition . ... and various other disciplines, will pitch their plans for ... of the competition. , ,Within the UW System, this ...
Cached Biology Technology:UW Madison launches new stem cell research program 2Valley Hospital implements API's solution for 3,500 employees 2Students compete for $22,000 in Tech Business Plan Competition 2Students compete for $22,000 in Tech Business Plan Competition 3
(Date:9/30/2014)... aquatic environment on Earth, but when the climate changes ... the limit. The amount of time needed to adjust ... species cope in the future, reveals a new study ... the scientific journal Proceedings of the Royal Society ... increasing levels of greenhouse gases in the atmosphere. The ...
(Date:9/30/2014)... in Munich report that a new class of ... chemotherapeutic drugs. They have also pinpointed the relevant ... anti-tumor agents. , Researchers led by LMU,s ... the Technische Universitt Mnchen have identified a class ... in the fight against malignant tumors. The compound ...
(Date:9/30/2014)... , Sept. 30, 2014  Spectra Automation, ... for the biotech and power generation industries, ... RECONN Bioprocess Manager, an easy-to-use and cost-effective ... towards bioprocess development laboratories. ... bioreactor and analyzer systems. Accessing and consolidating ...
Breaking Biology News(10 mins):Shape up quickly -- applies to fish, too! 2Cancer therapy: Driving cancer cells to suicide 2Spectra Automation Introduces RECONN Bioprocess Manager 2
... the Howard Hughes Medical Institute have succeeded in mapping ... wide range of odors, including vanilla, skunk, fish, urine, ... ?patterns of neural activity represents a significant step in ... receptors in the nose into odor perception in the ...
... What does it take to fathom a proverb ?catch the ... tree"? , According to research led by V. S. Ramachandran, ... University of California, San Diego, a region of the brain ... responsible for the human ability to understand metaphor. , Ramachandran ...
... three months after deciding to create an electronic ... registry and results database using an independent host, ... can be accessed by anyone, anywhere, with no ... patients and healthcare providers ready access to information ...
Cached Biology News:Decoding the logic of olfaction 2Decoding the logic of olfaction 3Decoding the logic of olfaction 4Grasping metaphors: UC San Diego research ties brain area to figures of speech 2Roche clinical trial registry and results database launched 2Roche clinical trial registry and results database launched 3